Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP, 2016 Statins and Type 2 Diabetes Mellitus: An Update After 1 Year. Curr Pharm Des. [Epub ahead of print] PubMed PMID: 26806344.Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Statins and Type 2 Diabetes Mellitus: An ...
One measure of obesity is body mass index (BMI), which estimates body fat based on weight and height. For men and those assigned male at birth who are older than 18, the lifetime risk of getting type 2 diabetes with a BMI of 18.5 or lower is 7%. The risk increases as your BMI inc...
[摘要] 目的 研究他汀类药物在治疗2型糖尿病患者高脂血症的疗效和成本,找出一种费用较低、效果显著的治疗方案。方法 将收治的168例2型糖尿病高脂血症患者随机分为为A(氟伐他汀)、B(洛伐他汀)、C(普伐他汀)、D(辛伐他汀)4组,比较各组疗效,并进行成本-效果分析。结果 A、B、C、D组疗效分别为85.71%、...
David Morris There is strong evidence that early-onset type 2 diabetes (commonly defined as that occurring in people under the age of 40 years) is a m...
Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2 diabetes mellitus (T2DM), particularly in low- and middle-income countries. To effectively prevent the development of CVDs in T2DM, considerable effort has been made to explore novel preventive approaches, individu...
We developed a deep-learning-based framework, multi-omics variational autoencoders (MOVE), to integrate such data and applied it to a cohort of 789 people with newly diagnosed type 2 diabetes with deep multi-omics phenotyping from the DIRECT consortium. Using in silico perturbations, we ...
OBJECTIVES: To compare the knowledge, attitude, and practice of pharmacists and physicians towards statins utilization in outpatients with type 2 diabetes. METHODS: A cross-sectional study was done at Penang General Hospital, from Januar...
There is a paucity of contemporary data on the prevalence and prognostic significance of cardiac autonomic neuropathy (CAN) from community-based cohorts with type 2 diabetes assessed using gold standard methods. The aim of this study was to assess these aspects of CAN in the longitudinal observation...
Statins for people with type 1 diabetes: when should treatment start?Statins for people with type 1 diabetes: when should treatment start?doi:10.1002/pdi.1990Miles Fisher MDGlasgow Royal InfirmaryFRCP Consultant PhysicianGlasgow Royal InfirmaryPractical Diabetes...
To prevent or at least delay complications, regular follow-up visits and good control of HbA1c, LDL-C, blood pressure, and other CVD risk factors are vital in diabetes management3. International and national guidelines have consistently identified statins as the principal lipid-lowering therapy, ...